Genomics

Dataset Information

Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming


ABSTRACT: Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming

PROVIDER: PRJNA588271 | ENA |

REPOSITORIES: ENA